Discover trends, market shifts, and competitive outlooks for the tumor ablation therapy devices industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What Is the Current and Projected Market Size of the Tumor Ablation Therapy Devices Market Through 2034?
The market size for tumor ablation therapy devices has significantly expanded in the past few years. The market, which was valued at $0.72 billion in 2024, is expected to scale up to $0.83 billion in 2025, showcasing a compound annual growth rate (CAGR) of 15.0%. The surge during the historical years is largely due to factors such as the rising occurrences of cancer, technological progressions, an increasing elderly population, and the popularity of minimally invasive procedures.
Significant expansion is anticipated for the tumor ablation therapy devices market in the coming years, with projections indicating it will reach $1.44 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 14.8%. This potential growth during the forecast period can be attributed to factors such as personalized medicine, combination treatments, AI involvement in image-guided ablation, telemedicine, and remote consultations, as well as education and training. Noteworthy trends anticipated during this term include advancements in ablation procedures, the use of imaging for guidance, assistance from robotics and navigation, integration with immuno-oncology, and the adoption of percutaneous and image-guided ablation.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3351&type=smp
What Are the Primary Drivers Supporting the Market Growth of the Tumor Ablation Therapy Devices Market?
The rise in cancer incidences is significantly contributing to the expansion of the tumor ablation therapy devices market. Globally, cancer accounts for the second most number of deaths, causing one in every six fatalities. Tumor ablation therapy, a less intrusive procedure, is extensively employed in the treatment of tumors in the lungs, liver, kidneys, and bones. The American Cancer Society Inc., a non-profit health organization based in the U.S., projects that in 2023, the number of new cancer diagnoses in the U.S. will rise to 1,958,310. This is an increase from more than 1,918,030 new cases reported in 2022. Tumor ablation therapy is a particularly effective treatment for patients who have not responded to chemotherapy or radiotherapy, hence bolstering the growth of its device market.
Which Primary Segments of the Tumor Ablation Therapy Devices Market Are Driving Growth and Industry Transformations?
The tumor ablation therapy devices market covered in this report is segmented –
1) By Technology: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation, Other Technologies
2) By Treatment: Surgical, Laparoscopic, Percutaneous
3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Applications
4) By End User: Hospitals, Oncology Clinics, Other End Users
Subsegments:
1) By Radiofrequency Ablation (RFA): Monopolar RFA Devices, Bipolar RFA Devices
2) By Microwave Ablation: High-frequency Microwave Devices, Low-frequency Microwave Devices
3) By Cryoablation: Liquid Nitrogen-based Devices, Argon Gas-based Devices
4) By Irreversible Electroporation Ablation (IRE): NanoKnife Ablation Systems, High-voltage Pulse Generators
5) By Other Technologies: Laser Ablation Devices, Ultrasound-guided High-intensity Focused Ultrasound (HIFU), Chemical Ablation Techniques
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=3351&type=smp
Which Regions Are Key Players in the Growth of the Tumor Ablation Therapy Devices Market?
North America was the largest region in the tumor ablation therapy devices market in 2023. Asia-Pacific was the second largest region in the tumor ablation therapy devices market. The regions covered in the tumor ablation therapy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Which Emerging Trends that Are Influencing the Tumor Ablation Therapy Devices Industry Evolution?
Top firms in the tumour ablation therapy device industry, such as J&J Medicals, are prioritizing technological breakthroughs to develop more efficient procedures, enhanced safety measures, reduced radiation exposure, and sped-up learning curves, all aiming for better outcomes. One of their innovations is the NEUWAVE microwave ablation system. This pioneering, minimally invasive tool introduces electrodes into cancer cells, amplifying the temperature surrounding the cells, thereby incinerating them. In a related development, in April 2023, Taiwan’s Compal Electronics introduced AblatePal, an innovative radiofrequency ablation (RFA) system. This setup, specifically designed for percutaneous, intraoperative coagulation and ablation of soft tissue, caters to the partial or full treatment of non-resectable liver lesions. The tool operates by employing heat energy generated through electrical resistance when the current traverses the tissue, ultimately leading to the elimination of the targeted tissue in question. AblatePal is a versatile system, with application in therapeutic medical devices and purposefully created to treat a diverse range of medical conditions, notably cancer.
View the full report here:
What Parameters Are Used to Define the Tumor Ablation Therapy Devices Market?
Tumor ablation therapy devices are minimally invasive devices used in the treatment of tumors, commonly of kidney, liver, and lung. These devices work by employing various techniques to destroy cancerous cells while preserving surrounding healthy tissue.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3351
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
